Drug use in first pregnancy and lactation: A population-based survey among Danish women

European Journal of Clinical Pharmacology

Volumn 55, Issue 2, 1999, Pages 139-144

  Olesen, Charlotte ^a   Steffensen, Flemming Hald ^a   Nielsen, Gunnar Lauge ^b   De Jong Van Den Berg, Lolkje ^c   Olsen, Jørn ^a   Sørensen, Henrik Toft ^d   Czeicel, Andrew ^e   Irgens, Lorentz ^e   Bergman, Ulf ^e   Pedersen, Lars ^e   Lie, Rolv T ^e   De Vries, Corinne ^e   Leurquin, Patrick ^e  

^a UNIVERSITY OF AARHUS   (Denmark)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d AARHUS UNIVERSITY HOSPITAL   (Denmark)

^e NONE

Author keywords

Population based utilization study; Post partum; Pregnancy

Indexed keywords

AGENTS ACTING ON THE EYE; ANTACID AGENT; ANTIASTHMATIC AGENT; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CORTICOSTEROID; MACROLIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN DERIVATIVE; SULFONAMIDE;

ADULT; ARTICLE; DRUG UTILIZATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; POLYPHARMACY; PREGNANCY; PRESCRIPTION; PRIMIGRAVIDA; PRIORITY JOURNAL; PUERPERIUM; REIMBURSEMENT;

ADULT; DENMARK; DRUG UTILIZATION; FEMALE; HUMANS; LACTATION; PARITY; POPULATION SURVEILLANCE; POSTPARTUM PERIOD; PRECONCEPTION CARE; PREGNANCY; PRESCRIPTIONS, DRUG;

EID: 0033045644     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050608     Document Type: Article

References (31)

1. Czeizel AE (1996) Recommendation to avoid all drugs during first trimester is unrealistic. BMJ 313: 424-425
2. Wood JJA (1998) Drugs in pregnancy. N Engl J Med 338: 1128-1137
3. Brocklebank JC, Ray WA, Federspiel CF, Schaffner W (1978) Drug prescribing during pregnancy. A controlled study of Tennessee Medicaid recipients. Am J Obstet Gynecol 132: 235-244
4. Peters PW, Garbis Berkvens HM, Bannigan JG (1993) Drugs of choice in pregnancy: primary prevention of birth defects. Reprod Toxicol 7: 399-404
5. Rubin PC, Craig GF, Gavin K, Sumner D (1986) Prospective survey of use of therapeutic drugs, alcohol, and cigarettes during pregnancy. BMJ 292: 81-83
6. Bonati M, Bortolus R, Marchetti F, Romero M, Tognoni G (1990) Drug use in pregnancy: an overview of epidemiological (drug utilization) studies. Eur J Clin Pharmacol 38: 325-328
7. Boethius G (1977) Recording of drug prescriptions in the country of Jamtland, Sweden. II. Drug exposure of pregnant women in relation to course and outcome of pregnancy. Eur J Clin Pharmacol 12: 37-43
8. Piper JM, Baum C, Kennedy DL (1987) Prescription drug use before and during pregnancy in a Medicaid population. Am J Obstet Gynecol 157: 148-156
9. Hill RM (1997) Drugs ingested by pregnant women. Clin Pharmacol Ther 14: 654-659
10. Collaborative Group on Drug Use in Pregnancy (1992) Medication during pregnancy: an intercontinental cooperative study. Int J Gynaecol Obstet 39: 185-196
11. Kullander S, Kallen B (1976) A prospective study of drugs and pregnancy. 4. Miscellaneous drugs. Acta Obstet Gynecol Scand 55: 287-295
12. Merlob P, Stahl B, Kaplan B (1996) Children born to mothers using multiple drug therapy during their pregnancy. Int Risk and Safety Med 8: 237-241
13. Hartwig H, Rohloff P, Huller H, Amon I (1982) Drugs in pregnancy - a prospective study. Int J Biol Res Pregnancy 3: 51-55
14. Hemminki E, Mantyranta T, Malin M, Koponen P (1991) A survey on the use of alternative drugs during pregnancy. Scand J Soc Med 19: 199-204
15. Rubin JD, Ferencz C, Loffredo C (1993) Use of prescription and non-prescription drugs in pregnancy. The Baltimore-Washington Infant Study Group. J Clin Epidemiol 46: 581-589
16. Bar J, Hod M, Merlob P (1997) Angiotensin converting enzyme inhibitor use in the first trimester of pregnancy. Int Risk Safety Med 10: 23-25
17. Pryde PG, Stedman AB, Nugent CE, Barr M (1993) Angiotensin converting enzyme inhibitor foetopathy. J Am Soc Nephrol 3: 1575-1582
18. Reinisch JM, Sanders SA, Mortensen EL, Rubin DB (1995) In utero exposure to phenobarbital and intelligence deficits in adult men. JAMA 274: 1518-1525
19. Dolovich LR, Addis A, Vaillancourt JD, Power B, Koren G, Einarson TR (1998) Benzodiazepine use in pregnancy and major malformations or oral cleft: meta-analysis of cohort and case-control studies. BMJ 317: 839-843
20. Nielsen GL, Sorensen HT, Weijin Z, Steffensen FH, Olsen JH (1997) The pharmacoepidemiologic prescription database of North Jutland. Int Risk Safety Med 10: 203-205
21. Dukes MN (1993) Drug utilization studies. Methods and uses. WHO Regional Publications, European Series, No. 45
22. Gaist D, Sorensen HT, Hallas J (1997) The Danish prescription registries. Danish Medical Bulletin 44: 445-448
23. de Jong-van den Berg LT, Van den Berg PB, Haaijer Ruskamp FM, Dukes MN, Wesseling H (1991) Investigating drug use in pregnancy. Methodological problems and perspectives. Pharm Weekbl Sci 13: 32-38
24. Irl C, Kipferler K, Hasford J (1997) Drug use assessment and risk evaluation in pregnancy - The Pegasus Project. Pharmacoepidemiol Drug Saf 6: S37-S42
25. Murray L, Seger D (1994) Drug therapy during pregnancy and lactation. Emerg Med Clin North Am 12: 129-149
26. Van den Berg de Jong LTW, Van den Berg PB, Peters PWJ, Haaijer-Ruskamp FM (1990) A study of drug utilization in pregnancy in the light of known risks: is there room for improvement? Int Risk Safety Med 1: 91-105
27. McCarty M (1994) Bromocriptine not for lactation suppression. Lancet 344: 602
28. Rothman KJ, Funch DP, Dreyer NA (1990) Bromocriptine and puerpural seizures. Epidemiology 1: 232-238
29. Fournié A, Graile Y, Montastruc JL (1994) Bromocriptine lactation inhibition and pharmacovigilance. J Gynecol Obstet Biol Reprod 23: 129-130
30. Millar LK, Cox SM (1997) Urinary tract infections complicating pregnancy. Infect Dis Clin North Am 11: 13-26
31. Garbaciak JA (1992) Prematurity prevention: who is at risk? Clin Perinatol 19: 275-289